808 related articles for article (PubMed ID: 25605649)
1. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
2. Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress.
Awad S; Al-Haffar KM; Marashly Q; Quijada P; Kunhi M; Al-Yacoub N; Wade FS; Mohammed SF; Al-Dayel F; Sutherland G; Assiri A; Sussman M; Bers D; Al-Habeeb W; Poizat C
J Pathol; 2015 Mar; 235(4):606-18. PubMed ID: 25421395
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure.
Dai DF; Johnson SC; Villarin JJ; Chin MT; Nieves-Cintrón M; Chen T; Marcinek DJ; Dorn GW; Kang YJ; Prolla TA; Santana LF; Rabinovitch PS
Circ Res; 2011 Apr; 108(7):837-46. PubMed ID: 21311045
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.
Adams JW; Sakata Y; Davis MG; Sah VP; Wang Y; Liggett SB; Chien KR; Brown JH; Dorn GW
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10140-5. PubMed ID: 9707614
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
Satoh M; Matter CM; Ogita H; Takeshita K; Wang CY; Dorn GW; Liao JK
Circulation; 2007 Jun; 115(25):3197-204. PubMed ID: 17562954
[TBL] [Abstract][Full Text] [Related]
7. CaMKIIδC Drives Early Adaptive Ca
Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
[TBL] [Abstract][Full Text] [Related]
8. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
9. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
[TBL] [Abstract][Full Text] [Related]
10. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
11. Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy.
Zhang M; Hagenmueller M; Riffel JH; Kreusser MM; Bernhold E; Fan J; Katus HA; Backs J; Hardt SE
Hypertension; 2015 Feb; 65(2):335-44. PubMed ID: 25489064
[TBL] [Abstract][Full Text] [Related]
12. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.
Shi J; Zhang YW; Yang Y; Zhang L; Wei L
J Mol Cell Cardiol; 2010 Nov; 49(5):819-28. PubMed ID: 20709073
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.
Mishra S; Ling H; Grimm M; Zhang T; Bers DM; Brown JH
J Cardiovasc Pharmacol; 2010 Dec; 56(6):598-603. PubMed ID: 20531218
[TBL] [Abstract][Full Text] [Related]
14. Rescue of cardiac failing and remodelling by inhibition of protein phosphatase 1γ is associated with suppression of the alternative splicing factor-mediated splicing of Ca2+/calmodulin-dependent protein kinase δ.
Liao RJ; Tong LJ; Huang C; Cao WW; Wang YZ; Wang J; Chen XF; Zhu WZ; Zhang W
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):976-85. PubMed ID: 25224648
[TBL] [Abstract][Full Text] [Related]
15. Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
Syed F; Odley A; Hahn HS; Brunskill EW; Lynch RA; Marreez Y; Sanbe A; Robbins J; Dorn GW
Circ Res; 2004 Dec; 95(12):1200-6. PubMed ID: 15539635
[TBL] [Abstract][Full Text] [Related]
16. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy.
Shi J; Zhang YW; Summers LJ; Dorn GW; Wei L
J Mol Cell Cardiol; 2008 Mar; 44(3):551-60. PubMed ID: 18178218
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of calcium/calmodulin-dependent protein kinase type II delta does not mitigate adverse myocardial remodeling in volume-overloaded hearts.
Mohamed BA; Elkenani M; Jakubiczka-Smorag J; Buchholz E; Koszewa S; Lbik D; Schnelle M; Hasenfuss G; Toischer K
Sci Rep; 2019 Jul; 9(1):9889. PubMed ID: 31285482
[TBL] [Abstract][Full Text] [Related]
18. RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.
van den Hoogenhof MMG; Beqqali A; Amin AS; van der Made I; Aufiero S; Khan MAF; Schumacher CA; Jansweijer JA; van Spaendonck-Zwarts KY; Remme CA; Backs J; Verkerk AO; Baartscheer A; Pinto YM; Creemers EE
Circulation; 2018 Sep; 138(13):1330-1342. PubMed ID: 29650543
[TBL] [Abstract][Full Text] [Related]
19. CaMKIIδ mediates β-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic β-adrenergic stimulation.
Grimm M; Ling H; Willeford A; Pereira L; Gray CB; Erickson JR; Sarma S; Respress JL; Wehrens XH; Bers DM; Brown JH
J Mol Cell Cardiol; 2015 Aug; 85():282-91. PubMed ID: 26080362
[TBL] [Abstract][Full Text] [Related]
20. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
